Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Hartford Hospital

Hartford Hospital in Hartford, Connecticut, United States is listed as a site for 518 registered clinical trials, 162 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 518
Ongoing 162

This page covers the site record Hartford Hospital in Hartford, Connecticut, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Hartford Hospital, also sponsors trials.

Get the Hartford Hospital report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 518 trials counted.

  • Phase 1 25 trials
  • Phase 1/2 5 trials
  • Phase 2 77 trials
  • Phase 2/3 24 trials
  • Phase 3 151 trials
  • Phase 4 30 trials
  • Not applicable 135 trials
  • Observational 69 trials
  • Expanded access 2 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 162 trials
  • Completed 265 trials
  • Terminated 48 trials
  • Other 43 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 35

1992: 1 trials (Observational 1) 1994: 1 trials (Phase 3 1) 1995: 1 trials (Phase 3 1) 1996: 1 trials (Observational 1) 1997: 1 trials (Phase 3 1) 1998: 2 trials (Phase 3 1, Phase 2 1) 1999: 4 trials (Not applicable 1, Phase 3 3) 2000: 3 trials (Phase 3 2, Phase 2 1) 2001: 3 trials (Phase 3 2, Phase 2/3 1) 2002: 3 trials (Observational 1, Phase 2/3 1, Phase 2 1) 2003: 9 trials (Not applicable 3, Phase 3 4, Phase 2 1, Phase 1 1) 2004: 5 trials (Observational 1, Not applicable 1, Phase 4 1, Phase 3 1, Phase 2 1) 2005: 12 trials (Observational 1, Not applicable 2, Phase 3 4, Phase 2 5) 2006: 11 trials (Observational 2, Not applicable 2, Phase 4 2, Phase 3 4, Phase 2 1) 2007: 17 trials (Observational 3, Not applicable 3, Phase 3 5, Phase 2 6) 2008: 22 trials (Not applicable 3, Phase 3 8, Phase 2/3 2, Phase 2 8, Phase 1 1) 2009: 29 trials (Not applicable 8, Phase 4 1, Phase 3 13, Phase 2 6, Phase 1 1) 2010: 34 trials (Observational 5, Not applicable 6, Phase 4 2, Phase 3 10, Phase 2/3 1, Phase 2 9, Phase 1 1) 2011: 17 trials (Observational 2, Not applicable 2, Phase 3 8, Phase 2 4, Phase 1 1) 2012: 35 trials (Observational 7, Not applicable 12, Phase 4 1, Phase 3 8, Phase 2/3 1, Phase 2 5, Phase 1 1) 2013: 17 trials (Observational 3, Not applicable 2, Phase 4 1, Phase 3 7, Phase 2 3, Phase 1 1) 2014: 30 trials (Observational 1, Not applicable 10, Phase 4 1, Phase 3 7, Phase 2/3 6, Phase 2 4, Phase 1 1) 2015: 20 trials (Observational 4, Not applicable 7, Phase 4 2, Phase 3 6, Phase 1/2 1) 2016: 19 trials (Observational 2, Not applicable 7, Phase 4 3, Phase 3 3, Phase 2/3 1, Phase 2 1, Phase 1 2) 2017: 22 trials (Observational 4, Not applicable 7, Phase 4 2, Phase 3 3, Phase 2/3 2, Phase 2 4) 2018: 15 trials (Observational 2, Not applicable 5, Phase 4 1, Phase 3 4, Phase 2 2, Phase 1 1) 2019: 30 trials (Observational 6, Not applicable 6, Phase 4 2, Phase 3 7, Phase 2/3 3, Phase 2 4, Phase 1 2) 2020: 26 trials (Observational 4, Not applicable 9, Phase 3 5, Phase 2/3 2, Phase 2 2, Phase 1/2 1, Phase 1 3) 2021: 25 trials (Observational 4, Not applicable 5, Phase 3 8, Phase 2 2, Phase 1/2 2, Phase 1 4) 2022: 24 trials (Observational 4, Not applicable 7, Phase 4 5, Phase 3 2, Phase 2/3 1, Phase 2 1, Phase 1/2 1, Phase 1 3) 2023: 31 trials (Observational 8, Not applicable 10, Phase 4 5, Phase 3 6, Phase 2/3 1, Phase 1 1) 2024: 22 trials (Observational 1, Not applicable 10, Phase 4 1, Phase 3 4, Phase 2/3 1, Phase 2 4, Phase 1 1) 2025: 17 trials (Observational 2, Not applicable 5, Phase 3 9, Phase 2/3 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 7
2025 17
2024 22
2023 31
2022 24
2021 25
2020 26
2019 30
2018 15
2017 22

Showing 10 of 34 years.

Start your 14-day trial Email me all 34 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 518 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 125 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 267 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF